The latest closing stock price for Sonnet BioTherapeutics Holdings as of September 18, 2024 is 1.00.
An investor who bought $1,000 worth of Sonnet BioTherapeutics Holdings stock at the IPO in 2006 would have $-1,000 today, roughly -1 times their original investment - a -53.59% compound annual growth rate over 18 years.
The all-time high Sonnet BioTherapeutics Holdings stock closing price was 1000999.88 on October 31, 2006.
The Sonnet BioTherapeutics Holdings 52-week high stock price is 3.30, which is 230% above the current share price.
The Sonnet BioTherapeutics Holdings 52-week low stock price is 0.62, which is 38% below the current share price.
The average Sonnet BioTherapeutics Holdings stock price for the last 52 weeks is 1.52.
An investor who bought $1,000 worth of Sonnet BioTherapeutics Holdings stock at the IPO in 2006 would have $-1,000 today, roughly -1 times their original investment - a -53.59% compound annual growth rate over 18 years.
The all-time high Sonnet BioTherapeutics Holdings stock closing price was 1000999.88 on October 31, 2006.
The Sonnet BioTherapeutics Holdings 52-week high stock price is 3.30, which is 230% above the current share price.
The Sonnet BioTherapeutics Holdings 52-week low stock price is 0.62, which is 38% below the current share price.
The average Sonnet BioTherapeutics Holdings stock price for the last 52 weeks is 1.52.